These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 28822618
1. The impact of incident depression on medication adherence in patients with type 2 diabetes. Lunghi C, Zongo A, Moisan J, Grégoire JP, Guénette L. Diabetes Metab; 2017 Dec; 43(6):521-528. PubMed ID: 28822618 [Abstract] [Full Text] [Related]
2. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression. Lunghi C, Zongo A, Moisan J, Grégoire JP, Guénette L. J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698 [Abstract] [Full Text] [Related]
3. The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs. Lunghi C, Moisan J, Grégoire JP, Guénette L. Value Health; 2017 Jun; 20(6):728-735. PubMed ID: 28577689 [Abstract] [Full Text] [Related]
4. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes. Tan E, Yang W, Pang B, Dai M, Loh FE, Hogan P. J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968 [Abstract] [Full Text] [Related]
5. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression. Xing S, Calip GS, Leow AD, Kim S, Schumock GT, Touchette DR, Lee TA. J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744 [Abstract] [Full Text] [Related]
6. Incidence of Depression and Associated Factors in Patients With Type 2 Diabetes in Quebec, Canada: A Population-Based Cohort Study. Lunghi C, Moisan J, Grégoire JP, Guénette L. Medicine (Baltimore); 2016 May; 95(21):e3514. PubMed ID: 27227919 [Abstract] [Full Text] [Related]
7. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization. Sun P, Lian J. Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064 [Abstract] [Full Text] [Related]
8. Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008. Gentil L, Vasiliadis HM, Préville M, Berbiche D. Prev Chronic Dis; 2015 Dec 31; 12():E230. PubMed ID: 26719900 [Abstract] [Full Text] [Related]
9. Impact of a diabetes remote monitoring program on medication adherence. Munshi KD, Amelung K, Carter CS, James R, Shah BR, Henderson RR. J Manag Care Spec Pharm; 2021 Jun 31; 27(6):724-731. PubMed ID: 34057390 [Abstract] [Full Text] [Related]
10. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. Guénette L, Breton MC, Guillaumie L, Lauzier S, Grégoire JP, Moisan J. J Diabetes Complications; 2016 Mar 31; 30(2):335-42. PubMed ID: 26615905 [Abstract] [Full Text] [Related]
11. Depression and antecedent medication adherence in a cohort of new metformin users. Niaz D, Necyk C, Simpson SH. Diabet Med; 2021 Feb 31; 38(2):e14426. PubMed ID: 33064895 [Abstract] [Full Text] [Related]
12. Association Between Metformin Adherence and All-Cause Mortality Among New Users of Metformin: A Nested Case-Control Study. Simard P, Presse N, Roy L, Dorais M, White-Guay B, Räkel A, Perreault S. Ann Pharmacother; 2018 Apr 31; 52(4):305-313. PubMed ID: 29144162 [Abstract] [Full Text] [Related]
13. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI. Ye X, Qian C, Liu J, St Peter WL. Pharmacotherapy; 2013 Oct 31; 33(10):1062-70. PubMed ID: 23798059 [Abstract] [Full Text] [Related]
14. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis. Adeyemi AO, Rascati KL, Lawson KA, Strassels SA. Clin Ther; 2012 Mar 31; 34(3):712-9. PubMed ID: 22381712 [Abstract] [Full Text] [Related]
15. Measuring adherence to oral antidiabetic multi-drug treatment: Comparative validity of prescription claims-based adherence measures against hospitalization. Zongo A, Grégoire JP, Moisan J, Guénette L. Res Social Adm Pharm; 2019 Jun 31; 15(6):738-743. PubMed ID: 30253976 [Abstract] [Full Text] [Related]
16. Oral antidiabetic drug use and associated health outcomes in cancer patients. Tan X, Feng X, Chang J, Higa G, Wang L, Leslie D. J Clin Pharm Ther; 2016 Oct 31; 41(5):524-31. PubMed ID: 27453485 [Abstract] [Full Text] [Related]
17. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Adv Ther; 2012 Aug 31; 29(8):675-90. PubMed ID: 22898791 [Abstract] [Full Text] [Related]
18. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Hertz RP, Unger AN, Lustik MB. Clin Ther; 2005 Jul 31; 27(7):1064-73. PubMed ID: 16154485 [Abstract] [Full Text] [Related]
19. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO, Barner JC, Rascati KL, Strassels SA. Clin Ther; 2012 Mar 31; 34(3):605-13. PubMed ID: 22386828 [Abstract] [Full Text] [Related]
20. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore. Cheen HH, Lim SH, Huang MC, Bee YM, Wee HL. Clin Ther; 2014 Jul 01; 36(7):1043-53. PubMed ID: 24913030 [Abstract] [Full Text] [Related] Page: [Next] [New Search]